The introduction of prostate-specific antigen (PSA)–based screening for prostate cancer in the early 1990s was followed by a nearly 2-decade long decline
Prostate Cancer Diagnostics Industry is projected to witness a CAGR of 12.4% during the period 2023-2032. This progression can be attributed to the increasing popularity of prostate cancer diagnostic tests.
Guerbet Wins PI-CAI Grand Challenge on Detection of Prostate Cancer itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.